Literature DB >> 16080084

Patient-delivered partner treatment for male urethritis: a randomized, controlled trial.

Patricia Kissinger1, Hamish Mohammed, Gwangi Richardson-Alston, Jami S Leichliter, Stephanie N Taylor, David H Martin, Thomas A Farley.   

Abstract

BACKGROUND: Traditional partner referral for sexually transmitted diseases (STDs) is ineffective at assuring that partners are treated. Alternative methods are needed. We sought to determine whether patient-delivered partner treatment (PDPT) is better than 2 different methods of partner referral in providing antibiotic treatment to sex partners of men with urethritis and in reducing recurrence of Chlamydia trachomatis and Neisseria gonorrhoeae.
METHODS: Men who received a diagnosis of urethritis at a public STD clinic in New Orleans, Louisiana, during the period of December 2001 through March 2004 were randomly assigned according to the month of treatment for either standard partner referral (PR), booklet-enhanced partner referral (BEPR), or PDPT. At baseline and after 1 month, men were asked to provide information about each partner and were tested for C. trachomatis and N. gonorrhoeae.
RESULTS: Most enrolled index men (n = 977) were > 24 years of age (51.6%) and African American (95%) and had > or = 2 partners (68.3%). They reported information on 1991 partners, and 78.8% were reinterviewed 4-8 weeks later. Men in the PDPT arm were more likely than men in the BEPR and PR arms to report having seen their partners, having talked to their partners about the infection, having given the intervention to their partners, and having been told by their partners that the antibiotic treatment had been taken (55.8%, 45.6%, and 35.0%, respectively; P < .001). Of men who were reinterviewed, 37.5% agreed to follow-up testing for N. gonorrhoeae and C. trachomatis infection. Those tested were similar to those not tested with regard to the study variables measured. Among those tested, men in the PDPT and BEPR arms were less likely than those in the PR arm to test positive for C. trachomatis and/or N. gonorrhoeae (23.0%, 14.3%, and 42.7%, respectively; P < .001).
CONCLUSION: Among heterosexual men with urethritis, PDPT was better than standard partner referral for treatment of partners and prevention of recurrence of C. trachomatis or N. gonorrhoeae infection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16080084     DOI: 10.1086/432476

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  37 in total

1.  State-level gonorrhea rates and expedited partner therapy laws: insights from time series analyses.

Authors:  K Owusu-Edusei; R Cramer; H W Chesson; T L Gift; J S Leichliter
Journal:  Public Health       Date:  2017-03-24       Impact factor: 2.427

2.  Azithromycin Treatment Failure for Chlamydia trachomatis Among Heterosexual Men With Nongonococcal Urethritis.

Authors:  Patricia J Kissinger; Scott White; Lisa E Manhart; Jane Schwebke; Stephanie N Taylor; Leandro Mena; Christine M Khosropour; Larissa Wilcox; Norine Schmidt; David H Martin
Journal:  Sex Transm Dis       Date:  2016-10       Impact factor: 2.830

3.  Sexually transmitted diseases treatment guidelines, 2015.

Authors:  Kimberly A Workowski; Gail A Bolan
Journal:  MMWR Recomm Rep       Date:  2015-06-05

Review 4.  Partner notification.

Authors:  Catherine Mathews; Nicol Coetzee
Journal:  BMJ Clin Evid       Date:  2009-05-20

5.  Sexually transmitted infections in Canada: A sticky situation.

Authors:  David N Fisman; Kevin B Laupland
Journal:  Can J Infect Dis Med Microbiol       Date:  2011       Impact factor: 2.471

6.  A historical note on the association between the legal status of expedited partner therapy and physician practice.

Authors:  Ryan Cramer; Matthew Hogben; H Hunter Handsfield
Journal:  Sex Transm Dis       Date:  2013-05       Impact factor: 2.830

7.  Innovations in sexually transmitted disease partner services.

Authors:  Matthew Hogben; Linda M Niccolai
Journal:  Curr Infect Dis Rep       Date:  2009-03       Impact factor: 3.725

Review 8.  Strategies for partner notification for sexually transmitted infections, including HIV.

Authors:  Adel Ferreira; Taryn Young; Catherine Mathews; Moleen Zunza; Nicola Low
Journal:  Cochrane Database Syst Rev       Date:  2013-10-03

Review 9.  Expedited partner therapy for sexually transmitted infections.

Authors:  Matthew Hogben; Sarah Kidd; Gale R Burstein
Journal:  Curr Opin Obstet Gynecol       Date:  2012-10       Impact factor: 1.927

Review 10.  The use of cephalosporins for gonorrhea: the impending problem of resistance.

Authors:  Pennan M Barry; Jeffrey D Klausner
Journal:  Expert Opin Pharmacother       Date:  2009-03       Impact factor: 3.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.